All Stories

  1. Effects of orexin receptor antagonism on human sleep architecture: A systematic review

    Article • Sleep Medicine Reviews, October 2020, Elsevier

    Prof daniel hoyer

  2. Circadian disruption impairs fear extinction and memory of conditioned safety in mice

    Article • Behavioural Brain Research, September 2020, Elsevier

    Prof daniel hoyer

  3. The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study

    Article • mSystems, May 2020, ASM Journals

    Prof daniel hoyer

  4. Long-term Outcomes After Controlled Oxygenated Rewarming of Human Livers Before Transplantation

    Article • Transplantation Direct, April 2020, Wolters Kluwer Health

    Prof daniel hoyer

  5. SMAD4 protein is decreased in the dorsolateral prefrontal and anterior cingulate cortices in schizophrenia

    Article • The World Journal of Biological Psychiatry, March 2020, Taylor & Francis

    Prof daniel hoyer

  6. Curcumin Attenuates Colistin-Induced Peripheral Neurotoxicity in Mice

    Article • ACS Infectious Diseases, February 2020, American Chemical Society (ACS)

    Prof daniel hoyer

  7. Hypnotics with novel modes of action

    Article • British Journal of Clinical Pharmacology, January 2020, Wiley

    Prof daniel hoyer

  8. Separating Probability and Reversal Learning in a Novel Probabilistic Reversal Learning Task for Mice

    Article • Frontiers in Behavioral Neuroscience, January 2020, Frontiers

    Prof daniel hoyer

  9. Distribution of 5-HT receptors in the central nervous system: an update

    Article • January 2020, Elsevier

    Prof daniel hoyer

  10. Synthesis and structure−activity relationships of teixobactin

    Article • Annals of the New York Academy of Sciences, December 2019, Wiley

    Prof daniel hoyer

  11. The BJP expects authors to share data

    Article • British Journal of Pharmacology, December 2019, Wiley

    Prof daniel hoyer

  12. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors

    Article • British Journal of Pharmacology, November 2019, Wiley

    Professor Alistair Mathie, Stephen Alexander, Prof daniel hoyer, Professor of Vascular Physiology Lucie Clapp

  13. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, October 2019, ASM Journals

    Prof daniel hoyer

  14. T-2 toxin neurotoxicity: role of oxidative stress and mitochondrial dysfunction

    Article • Archives of Toxicology, September 2019, Springer Science + Business Media

    Prof daniel hoyer

  15. Sex: A change in our guidelines to authors to ensure that this is no longer an ignored experimental variable

    Article • British Journal of Pharmacology, August 2019, Wiley

    Prof daniel hoyer

  16. The impact of backbone N ‐methylation on the structure‐activity relationship of Leu 10 ‐teixobactin

    Article • Journal of Peptide Science, August 2019, Wiley

    Prof daniel hoyer

  17. Sex differences in mouse models of fear inhibition: Fear extinction, safety learning, and fear–safety discrimination

    Article • British Journal of Pharmacology, April 2019, Wiley

    Prof daniel hoyer

  18. Contemporary Anti-Ebola Drug Discovery Approaches and Platforms

    Article • ACS Infectious Diseases, December 2018, American Chemical Society (ACS)

    Prof daniel hoyer

  19. Molecular Mechanisms of Neurotoxicity Induced by Polymyxins and Chemoprevention

    Article • ACS Chemical Neuroscience, October 2018, American Chemical Society (ACS)

    Prof daniel hoyer

  20. A Comparative Study of Outer Membrane Proteome between Paired Colistin-Susceptible and Extremely Colistin-Resistant Klebsiella pneumoniae Strains

    Article • ACS Infectious Diseases, September 2018, American Chemical Society (ACS)

    Prof daniel hoyer

  21. Reply to Tosh et al.: Quantitative analyses of cultural evolution require engagement with historical and archaeological research

    Article • Proceedings of the National Academy of Sciences, June 2018, Proceedings of the National Academy of Sciences

    Prof daniel hoyer, Professor ANDREY KOROTAEV

  22. Animal Models of Addiction and Neuropsychiatric Disorders and Their Role in Drug Discovery: Honoring the Legacy of Athina Markou

    Article • Biological Psychiatry, June 2018, Elsevier

    Prof daniel hoyer

  23. Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules

    Article • ACS Infectious Diseases, March 2018, American Chemical Society (ACS)

    Prof daniel hoyer

  24. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

    Article • British Journal of Pharmacology, March 2018, Wiley

    Stephen Alexander, Prof daniel hoyer

  25. Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology

    Article • British Journal of Pharmacology, January 2018, Wiley

    Stephen Alexander, Prof daniel hoyer

  26. The potentially beneficial central nervous system activity profile of ivacaftor and its metabolites

    Article • ERJ Open Research, January 2018, European Respiratory Society (ERS)

    Prof daniel hoyer

  27. Lemborexant. Dual orexin receptor antagonist, Treatment of insomnia

    Article • Drugs of the Future, January 2018, Thomson Reuters (Scientific) Inc. & Affiliates

    Prof daniel hoyer

  28. Mechanistic Insights From Global Metabolomics Studies into Synergistic Bactericidal Effect of a Polymyxin B Combination With Tamoxifen Against Cystic Fibrosis MDR Pseudomonas aeruginosa

    Article • Computational and Structural Biotechnology Journal, January 2018, Elsevier

    Prof daniel hoyer

  29. Polymyxins for CNS infections: Pharmacology and neurotoxicity

    Article • Pharmacology & Therapeutics, January 2018, Elsevier

    Prof daniel hoyer

  30. Rapamycin Confers Neuroprotection against Colistin-Induced Oxidative Stress, Mitochondria Dysfunction, and Apoptosis through the Activation of Autophagy and mTOR/Akt/CREB Signaling Pathways

    Article • ACS Chemical Neuroscience, December 2017, American Chemical Society (ACS)

    Prof daniel hoyer

  31. Orexin Receptor Antagonists

    Article • Current Sleep Medicine Reports, November 2017, Springer Science + Business Media

    Prof daniel hoyer

  32. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview

    Article • British Journal of Pharmacology, October 2017, Wiley

    Dr Christopher Southan, Dr Anthony P Davenport, Professor Israel Hanukoglu, Professor Jamie A Davies, Prof daniel hoyer, Professor of Vascular Physiology Lucie Clapp

  33. Updating the guidelines for data transparency in the British Journal of Pharmacology - data sharing and the use of scatter plots instead of bar charts

    Article • British Journal of Pharmacology, August 2017, Wiley

    Stephen Alexander, Prof daniel hoyer

  34. 5-HT Receptor Nomenclature: Naming Names, Does It Matter? A Tribute to Maurice Rapport

    Article • ACS Chemical Neuroscience, March 2017, American Chemical Society (ACS)

    Prof daniel hoyer

  35. A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment

    Article • Psychopharmacology, March 2017, Springer Science + Business Media

    Prof daniel hoyer

  36. Saving, changing and repairing lives

    Article • Impact, February 2017, Science Impact, Ltd.

    Prof daniel hoyer

  37. Blunted 5-HT1A receptor-mediated responses and antidepressant-like behavior in mice lacking the GABAB1a but not GABAB1b subunit isoforms

    Article • Psychopharmacology, January 2017, Springer Science + Business Media

    Prof daniel hoyer

  38. Astrocytes: Adhesion Molecules and Immunomodulation

    Article • Current Drug Targets, November 2016, Bentham Science Publishers

    Prof daniel hoyer

  39. Hippocampal 5-HT7receptors signal phosphorylation of the GluA1 subunit to facilitate AMPA receptor mediated-neurotransmissionin vitroandin vivo

    Article • British Journal of Pharmacology, March 2016, Wiley

    Prof daniel hoyer

  40. Editorial: Reporting guidelines for psychopharmacology

    Article • Psychopharmacology, February 2016, Springer Science + Business Media

    Prof daniel hoyer

  41. Orexin OX2 Receptor Antagonists as Sleep Aids

    Article • January 2016, Springer Science + Business Media

    Prof daniel hoyer

  42. The Concise Guide to PHARMACOLOGY 2015/16: Overview

    Article • British Journal of Pharmacology, December 2015, Wiley

    Dr Anthony P Davenport, Stephen Alexander, Prof daniel hoyer

  43. Discovery of 1 H -pyrazolo[3,4- b ]pyridines as potent dual orexin receptor antagonists (DORAs)

    Article • Bioorganic & Medicinal Chemistry Letters, December 2015, Elsevier

    Prof daniel hoyer

  44. Experimental design and analysis and their reporting: new guidance for publication in BJP

    Article • British Journal of Pharmacology, June 2015, Wiley

    Dr Annette Gilchrist, Stephen Alexander, Prof daniel hoyer

  45. Pathological Conditions Associated with the Disturbance of the 5-HT System

    Article • June 2015, Wiley

    Prof daniel hoyer

  46. AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: pharmacological characterization and phase I evaluation

    Article • British Journal of Pharmacology, January 2015, Wiley

    Prof daniel hoyer

  47. Somatostatin

    Article • January 2015, Springer Science + Business Media

    Prof daniel hoyer

  48. Suvorexant for the treatment of insomnia

    Article • Expert Review of Clinical Pharmacology, October 2014, Taylor & Francis

    Prof daniel hoyer

  49. SOM230: A New Therapeutic Modality for Cushing's Disease

    Article • CHIMIA International Journal for Chemistry, August 2014, Swiss Chemical Society

    Prof daniel hoyer

  50. Somatostatin

    Article • January 2014, Springer Science + Business Media

    Prof daniel hoyer

  51. The Concise Guide to PHARMACOLOGY 2013/14: Overview

    Article • British Journal of Pharmacology, December 2013, Wiley

    Dr Anthony P Davenport, Stephen Alexander, Prof daniel hoyer

  52. Orexin in sleep, addiction and more: Is the perfect insomnia drug at hand?

    Article • Neuropeptides, December 2013, Elsevier

    Prof daniel hoyer

  53. An invitation for comprehensive single-compound reviews on the pharmacological properties of newly launched drugs

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, September 2013, Springer Science + Business Media

    Prof daniel hoyer

  54. Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia

    Article • Journal of Medicinal Chemistry, September 2013, American Chemical Society (ACS)

    Prof daniel hoyer

  55. Adult siRNA-induced knockdown of mGlu7 receptors reduces anxiety in the mouse

    Article • Neuropharmacology, September 2013, Elsevier

    Prof daniel hoyer

  56. Distinct effects of IPSU and suvorexant on mouse sleep architecture

    Article • Frontiers in Neuroscience, January 2013, Frontiers

    Prof daniel hoyer

  57. Kinetic properties of “dual” orexin receptor antagonists at OX1R and OX2R orexin receptors

    Article • Frontiers in Neuroscience, January 2013, Frontiers

    Prof daniel hoyer

  58. The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors

    Article • SLEEP, December 2012, Oxford University Press (OUP)

    Prof daniel hoyer

  59. Neuropeptides and Neuropeptide Receptors: Drug Targets, and Peptide and Non-Peptide Ligands: a Tribute to Prof.Dieter Seebach

    Article • Chemistry & Biodiversity, November 2012, Wiley

    Prof daniel hoyer

  60. Neuropeptidomics of mouse hypothalamus after imipramine treatment reveal somatostatin as a potential mediator of antidepressant effects

    Article • Neuropharmacology, January 2012, Elsevier

    Prof daniel hoyer

  61. Reviewer comments on Reflections on drug research by Sir James Black

    Article • British Journal of Pharmacology, October 2010, Wiley

    Prof daniel hoyer

  62. Somatostatin-28 modulates prepulse inhibition of the acoustic startle response, reward processes and spontaneous locomotor activity in rats

    Article • Neuropeptides, October 2010, Elsevier

    Prof daniel hoyer

  63. Neuropeptide receptor positive allosteric modulation in epilepsy: Galanin modulation revealed

    Article • Proceedings of the National Academy of Sciences, August 2010, Proceedings of the National Academy of Sciences

    Prof daniel hoyer

  64. Changes of AMPA receptors in MPTP monkeys with levodopa-induced dyskinesias

    Article • Neuroscience, June 2010, Elsevier

    Prof daniel hoyer

  65. Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst3 receptor antagonists

    Article • Bioorganic & Medicinal Chemistry Letters, March 2010, Elsevier

    Prof daniel hoyer

  66. Hippocampal sst1 receptors are autoreceptors and do not affect seizures in rats

    Article • Neuroreport, March 2010, Wolters Kluwer Health

    Prof daniel hoyer

  67. Reaction of Fe3(CO)12 with octreotide—chemical, electrochemical and biological investigations

    Article • Dalton Transactions, January 2010, Royal Society of Chemistry

    Dr Ulf-Peter Apfel, Prof daniel hoyer

  68. Distribution of 5-HT Receptors in the Central Nervous System

    Article • January 2010, Elsevier

    Prof daniel hoyer

  69. The mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease

    Article • Molecular Neurodegeneration, January 2010, Springer Science + Business Media

    Prof daniel hoyer

  70. NMR-Solution Structures and Affinities for the Human Somatostatin G-Protein-Coupled Receptors hsst1–5 of CF3 Derivatives of Sandostatin® (Octreotide)

    Article • Helvetica Chimica Acta, December 2009, Wiley

    Professor Antonio Togni, Prof daniel hoyer

  71. Somatostatin, Alzheimer's disease and cognition: An old story coming of age?

    Article • Progress in Neurobiology, October 2009, Elsevier

    Prof daniel hoyer

  72. Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 mice

    Article • Psychopharmacology, July 2009, Springer Science + Business Media

    Prof daniel hoyer

  73. Novel, Potent, and Radio-Iodinatable Somatostatin Receptor 1 (sst1) Selective Analogues

    Article • Journal of Medicinal Chemistry, May 2009, American Chemical Society (ACS)

    Prof daniel hoyer

  74. Discovery of novel non-peptidic β-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists

    Article • Bioorganic & Medicinal Chemistry Letters, March 2009, Elsevier

    Prof daniel hoyer

  75. New Perspective in Peptide Chemistry by N-Alkylation

    Article • January 2009, Springer Science + Business Media

    Prof daniel hoyer

  76. The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

    Article • Neuropharmacology, January 2009, Elsevier

    Prof daniel hoyer

  77. Increased exploratory activity of APP23 mice in a novel environment is reversed by siRNA

    Article • Brain Research, December 2008, Elsevier

    Prof daniel hoyer

  78. Molecular biology of 5-HT receptors

    Article • Behavioural Brain Research, December 2008, Elsevier

    Prof daniel hoyer

  79. Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain

    Article • Neuropsychopharmacology, September 2008, Springer Science + Business Media

    Prof daniel hoyer

  80. New Open-Chain and Cyclic Tetrapeptides, Consisting ofα-,β2-, andβ3-Amino-Acid Residues, as Somatostatin Mimics - A Survey

    Article • Helvetica Chimica Acta, September 2008, Wiley

    Dr Michael Limbach, Prof daniel hoyer

  81. The Enantiomer of Octreotate Binds to All Five Somatostatin Receptors with Almost Equal Micromolar Affinity - A Comparison withSANDOSTATIN®

    Article • Chemistry & Biodiversity, July 2008, Wiley

    Prof daniel hoyer

  82. Pharmacological profile of somatostatin and cortistatin receptors

    Article • Molecular and Cellular Endocrinology, May 2008, Elsevier

    Prof daniel hoyer

  83. The Rostral Anterior Cingulate Cortex Modulates the Efficiency of Amygdala-Dependent Fear Learning

    Article • Biological Psychiatry, May 2008, Elsevier

    Prof daniel hoyer

  84. Improving Oral Bioavailability of Peptides by Multiple N-Methylation: Somatostatin Analogues

    Article • Angewandte Chemie International Edition, March 2008, Wiley

    Prof daniel hoyer

  85. Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst1 receptor

    Article • Bioorganic & Medicinal Chemistry Letters, February 2008, Elsevier

    Prof daniel hoyer

  86. Brain sphingosine-1-phosphate receptors: Implication for FTY720 in the treatment of multiple sclerosis

    Article • Pharmacology & Therapeutics, January 2008, Elsevier

    Prof daniel hoyer

  87. mGluR7 facilitates extinction of aversive memories and controls amygdala plasticity

    Article • Molecular Psychiatry, August 2007, Springer Science + Business Media

    Prof daniel hoyer

  88. Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists

    Article • Bioorganic & Medicinal Chemistry Letters, July 2007, Elsevier

    Prof daniel hoyer

  89. SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists

    Article • Bioorganic & Medicinal Chemistry Letters, July 2007, Elsevier

    Prof daniel hoyer

  90. JN403, in vitro characterization of a novel nicotinic acetylcholine receptor α7 selective agonist

    Article • Neuroscience Letters, April 2007, Elsevier

    Prof daniel hoyer

  91. Emerging use of non-viral RNA interference in the brain

    Article • Biochemical Society Transactions, March 2007, Portland Press Ltd.

    Prof daniel hoyer

  92. 5-HT-5 Receptors

    Article • January 2007, Elsevier

    Prof daniel hoyer

  93. 5-HT-6 Receptor

    Article • January 2007, Elsevier

    Prof daniel hoyer

  94. 5-HT-7 Receptor

    Article • January 2007, Elsevier

    Prof daniel hoyer

  95. 5-HT-1F Receptor

    Article • January 2007, Elsevier

    Prof daniel hoyer

  96. 5-HT-3 Receptor

    Article • January 2007, Elsevier

    Prof daniel hoyer

  97. 5-Hydroxytryptamine Receptors

    Article • January 2007, Elsevier

    Prof daniel hoyer

  98. ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies

    Article • Bioorganic & Medicinal Chemistry, January 2007, Elsevier

    Prof daniel hoyer

  99. RNA interference as a therapeutic strategy for treating CNS disorders

    Article • Drug Discovery Today Therapeutic Strategies, December 2006, Elsevier

    Prof daniel hoyer

  100. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine

    Article • Molecular Psychiatry, October 2006, Springer Science + Business Media

    Prof daniel hoyer

  101. Somatostatin receptors in wildtype and somatostatin deficient mice and their involvement in nitric oxide physiology in the retina

    Article • Neuropeptides, October 2006, Elsevier

    Prof daniel hoyer

  102. The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?

    Article • Pharmacology & Therapeutics, June 2006, Elsevier

    Prof daniel hoyer

  103. Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission

    Article • European Journal of Neuroscience, May 2006, Wiley

    Prof daniel hoyer

  104. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice

    Article • Journal of Neurochemistry, May 2006, Wiley

    Prof daniel hoyer

  105. Interfering with the brain: Use of RNA interference for understanding the pathophysiology of psychiatric and neurological disorders

    Article • Pharmacology & Therapeutics, March 2006, Elsevier

    Prof daniel hoyer

  106. Global Down-Regulation of Gene Expression in the Brain Using RNA Interference, with Emphasis on Monoamine Transporters and GPCRs: Implications for Target Characterization in Psychiatric and Neurological Disorders

    Article • Journal of Receptors and Signal Transduction, January 2006, Taylor & Francis

    Prof daniel hoyer

  107. Correction: Opportunities in somatostatin research: biological, chemical and therapeutic aspects

    Article • Nature Reviews Drug Discovery, December 2005, Springer Science + Business Media

    Prof daniel hoyer

  108. Distinct functional properties of native somatostatin receptor subtype 5 compared with subtype 2 in the regulation of ACTH release by corticotroph tumor cells

    Article • AJP Endocrinology and Metabolism, August 2005, American Physiological Society

    Prof daniel hoyer

  109. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain

    Article • Molecular Psychiatry, July 2005, Springer Science + Business Media

    Prof daniel hoyer

  110. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain

    Article • Molecular Psychiatry, May 2005, Springer Science + Business Media

    Prof daniel hoyer

  111. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors

    Article • Neuropharmacology, May 2005, Elsevier

    Prof daniel hoyer

  112. Coupling of human nicotinic acetylcholine receptors α7 to calcium channels in GH3 cells

    Article • Neuropharmacology, February 2005, Elsevier

    Prof daniel hoyer

  113. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures

    Article • Autonomic and Autacoid Pharmacology, January 2005, Wiley

    Prof daniel hoyer

  114. Somatostatin Receptor 1 Selective Analogues:  2. Nα-Methylated Scan†

    Article • Journal of Medicinal Chemistry, January 2005, American Chemical Society (ACS)

    Prof daniel hoyer

  115. Proceedings of Neuropeptides 2004, the XIV European Neuropeptides Club meeting

    Article • Neuropeptides, December 2004, Elsevier

    Prof daniel hoyer

  116. Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference

    Article • Proceedings of the National Academy of Sciences, November 2004, Proceedings of the National Academy of Sciences

    Prof daniel hoyer

  117. Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices

    Article • European Journal of Neuroscience, November 2004, Wiley

    Prof daniel hoyer

  118. Paroxetine combined with a 5-HT1A receptor antagonist reversed reward deficits observed during amphetamine withdrawal in rats

    Article • Psychopharmacology, September 2004, Springer Science + Business Media

    Prof daniel hoyer

  119. The NK1 receptor antagonist NKP608 lacks anxiolytic-like activity in Swiss-Webster mice exposed to the elevated plus-maze

    Article • Behavioural Brain Research, September 2004, Elsevier

    Prof daniel hoyer

  120. The somatostatin receptor (sst1) modulates the release of somatostatin in the nucleus accumbens of the rat

    Article • Neuropharmacology, September 2004, Elsevier

    Prof daniel hoyer

  121. Effect of Somatostatin on Nitric Oxide Production in Human Retinal Pigment Epithelium Cell Cultures

    Article • Investigative Ophthalmology & Visual Science, May 2004, Association for Research in Vision and Ophthalmology (ARVO)

    Dr George Notas, Prof daniel hoyer

  122. Comparison of functional profiles at human recombinant somatostatin sst2receptor: simultaneous determination of intracellular Ca2+and luciferase expression in CHO-K1 cells

    Article • British Journal of Pharmacology, May 2004, Wiley

    Prof daniel hoyer

  123. SRA880, in vitro characterization of the first non-peptide somatostatin sst1 receptor antagonist

    Article • Neuroscience Letters, May 2004, Elsevier

    Prof daniel hoyer

  124. Applications of a Rat Multiple Tissue Gene Expression Data Set

    Article • Genome Research, April 2004, Cold Spring Harbor Laboratory Press

    Prof daniel hoyer

  125. Genetic deletion of somatostatin receptor 1 alters somatostatinergic transmission in the mouse retina

    Article • Neuropharmacology, December 2003, Elsevier

    Prof daniel hoyer

  126. Withdrawal from chronic amphetamine induces Depressive-Like behavioral effects in rodents

    Article • Biological Psychiatry, July 2003, Elsevier

    Prof daniel hoyer

  127. Native somatostatin sst2 and sst5 receptors functionally coupled to Gi/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, May 2003, Springer Science + Business Media

    Prof daniel hoyer

  128. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs

    Article • British Journal of Pharmacology, May 2003, Wiley

    Prof daniel hoyer

  129. Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists

    Article • European Journal of Pharmacology, April 2003, Elsevier

    Prof daniel hoyer

  130. Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1–sst5 receptor-selective nonpeptidyl agonists

    Article • Neuropharmacology, April 2003, Elsevier

    Prof daniel hoyer

  131. Design and Synthesis of γ-Dipeptide Derivatives with Submicromolar Affinities for Human Somatostatin Receptors

    Article • Angewandte Chemie International Edition, February 2003, Wiley

    Prof daniel hoyer

  132. β2/β3-di- and α/β3-tetrapeptide derivatives as potent agonists at somatostatin sst4 receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, February 2003, Springer Science + Business Media

    Prof daniel hoyer

  133. Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 2003, Springer Science + Business Media

    Prof daniel hoyer

  134. Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice

    Article • European Journal of Neuroscience, September 2002, Wiley

    Prof daniel hoyer

  135. Study of the calcium dynamics of the human α4β2, α3β4 and α1β1γδ nicotinic acetylcholine receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, September 2002, Springer Science + Business Media

    Prof daniel hoyer

  136. Molecular, pharmacological and functional diversity of 5-HT receptors

    Article • Pharmacology Biochemistry and Behavior, April 2002, Elsevier

    Prof daniel hoyer

  137. Identification and characterization of a type five-like somatostatin receptor in goldfish pituitary

    Article • Molecular and Cellular Endocrinology, March 2002, Elsevier

    Prof daniel hoyer

  138. Somatostatin sst2 receptor knock-out mice: localisation of sst1–5 receptor mRNA and binding in mouse brain by semi-quantitative RT–PCR, in situ hybridisation histochemistry and receptor autoradiography

    Article • Neuropharmacology, March 2002, Elsevier

    Prof daniel hoyer

  139. Emerging discoveries in neuroscience: molecular bridges to the brain

    Article • Current Opinion in Pharmacology, February 2002, Elsevier

    Prof daniel hoyer

  140. Pharmacological characterisation of the goldfish somatostatin sst5 receptor

    Article • European Journal of Pharmacology, February 2002, Elsevier

    Prof daniel hoyer

  141. Drug Design at Peptide Receptors

    Article • Journal of Molecular Neuroscience, January 2002, Springer Science + Business Media

    Prof daniel hoyer

  142. Extended Radioligand Binding Profile of Iloperidone A Broad Spectrum Dopamine/Serotonin/Norepinephrine Receptor Antagonist for the Management of Psychotic Disorders

    Article • Neuropsychopharmacology, December 2001, Springer Science + Business Media

    Prof daniel hoyer

  143. Linear, Peptidase-Resistantβ2/β3-Di- andα/β3-Tetrapeptide Derivatives with Nanomolar Affinities to a Human Somatostatin Receptor, Preliminary Communication

    Article • Helvetica Chimica Acta, November 2001, Wiley

    Professor Per I Arvidsson, Prof daniel hoyer

  144. Lack of evidence for cross-competition between vasoactive intestinal peptide and somatostatin at their respective receptors

    Article • European Journal of Pharmacology, August 2001, Elsevier

    Prof daniel hoyer

  145. Peptide Folding Induces High and Selective Affinity of a Linear and Small β-Peptide to the Human Somatostatin Receptor 4

    Article • Journal of Medicinal Chemistry, July 2001, American Chemical Society (ACS)

    Professor Karl Gademann, Prof daniel hoyer

  146. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery

    Article • Journal of Physiology-Paris, October 2000, Elsevier

    Prof daniel hoyer

  147. Recovery of emotional behaviour in neural cell adhesion molecule (NCAM) null mutant mice through transgenic expression of NCAM180

    Article • European Journal of Neuroscience, September 2000, Wiley

    Prof daniel hoyer

  148. Cloning, expression and pharmacological characterisation of the mouse somatostatin sst5 receptor

    Article • Neuropharmacology, July 2000, Elsevier

    Prof daniel hoyer

  149. Syntheses and biological activities of sandostatin analogs containing stereochemical changes in positions 6 or 8

    Article • Biopolymers, May 2000, Wiley

    Prof daniel hoyer

  150. Cloning, expression, functional coupling and pharmacological characterization of the rat dopamine D 4 receptor

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, April 2000, Springer Science + Business Media

    Prof daniel hoyer

  151. Potent and Selective Non-Peptidic Inhibitors of Endothelin-Converting Enzyme-1 with Sustained Duration of Action

    Article • Journal of Medicinal Chemistry, February 2000, American Chemical Society (ACS)

    Prof daniel hoyer

  152. The Cyclo-β-Tetrapeptide (β-HPhe-β-HThr-β-HLys-β-HTrp): Synthesis, NMR Structure in Methanol Solution, and Affinity for Human Somatostatin Receptors

    Article • Helvetica Chimica Acta, January 2000, Wiley

    Professor Karl Gademann, Prof daniel hoyer

  153. Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1999, Springer Science + Business Media

    Prof daniel hoyer

  154. Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPγS binding

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1999, Springer Science + Business Media

    Prof daniel hoyer

  155. Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1999, Springer Science + Business Media

    Prof daniel hoyer

  156. Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1999, Springer Science + Business Media

    Prof daniel hoyer

  157. Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis

    Article • European Journal of Neuroscience, November 1999, Wiley

    Prof daniel hoyer

  158. Receptor density as a factor governing the efficacy of the dopamine D4receptor ligands, L-745,870 and U-101958 at human recombinant D4.4receptors expressed in CHO cells

    Article • British Journal of Pharmacology, October 1999, Wiley

    Prof daniel hoyer

  159. Anxiety and increased 5-HT1A receptor response in NCAM null mutant mice

    Article • Journal of Neurobiology, September 1999, Wiley

    Prof daniel hoyer

  160. Molecular Cloning and Pharmacological Characterization of a Somatostatin Receptor Subtype in the Gymnotiform Fish Apteronotus albifrons

    Article • General and Comparative Endocrinology, September 1999, Elsevier

    Prof daniel hoyer

  161. Pharmacological characterisation of 5-HT receptors positively coupled to adenylyl cyclase in the rat hippocampus

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, June 1999, Springer Science + Business Media

    Prof daniel hoyer

  162. Structural and compositional determinants of cortistatin activity

    Article • Journal of Neuroscience Research, May 1999, Wiley

    Prof daniel hoyer

  163. Synthesis and Biological Evaluation of a Cyclo--tetrapeptide as a Somatostatin Analogue

    Article • Angewandte Chemie International Edition, May 1999, Wiley

    Professor Karl Gademann, Prof daniel hoyer

  164. Characterisation of the fish sst3 receptor, a member of the SRIF1 receptor family: atypical pharmacological features

    Article • Neuropharmacology, March 1999, Elsevier

    Prof daniel hoyer

  165. Preface

    Article • Annals of the New York Academy of Sciences, December 1998, Wiley

    Prof daniel hoyer

  166. High Affinity of SDZ HTF-919 and Related Molecules for Calf and Human Caudate 5-HT4 Receptors

    Article • Annals of the New York Academy of Sciences, December 1998, Wiley

    Prof daniel hoyer

  167. Impact of the Human Genome Project on the Principles for Classification and Nomenclature of 5-HT Receptors

    Article • Annals of the New York Academy of Sciences, December 1998, Wiley

    Prof daniel hoyer

  168. The role ofα2-adrenoceptor antagonism in the anti-cataleptic properties of the atypical neuroleptic agent, clozapine, in the rat

    Article • British Journal of Pharmacology, August 1998, Wiley

    Prof daniel hoyer

  169. Design, Synthesis, and Biological Activities of Potent and Selective Somatostatin Analogues Incorporating Novel Peptoid Residues

    Article • Journal of Medicinal Chemistry, July 1998, American Chemical Society (ACS)

    Prof daniel hoyer

  170. The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4receptor

    Article • British Journal of Pharmacology, July 1998, Wiley

    Prof daniel hoyer

  171. [125I]Tyr10-cortistatin14 labels all five somatostatin receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, May 1998, Springer Science + Business Media

    Prof daniel hoyer

  172. [][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors

    Article • European Journal of Pharmacology, May 1998, Elsevier

    Prof daniel hoyer

  173. The structure and signalling properties of 5-HT receptors: an endless diversity?

    Article • Trends in Pharmacological Sciences, January 1998, Elsevier

    Prof daniel hoyer

  174. Identification and pharmacological characterization of somatostatin receptors in rat lung

    Article • British Journal of Pharmacology, July 1997, Wiley

    Prof daniel hoyer

  175. 5-HT Receptor Classification and Nomenclature: Towards a Harmonization with the Human Genome

    Article • Neuropharmacology, April 1997, Elsevier

    Prof daniel hoyer

  176. Editorial

    Article • Neuropharmacology, April 1997, Elsevier

    Prof daniel hoyer

  177. Inhibition of cAMP Accumulation Via Recombinant Human Serotonin 5-HT 1A Receptors: Considerations on Receptor Effector Coupling across Systems

    Article • Neuropharmacology, April 1997, Elsevier

    Prof daniel hoyer

  178. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 1997, Springer Science + Business Media

    Prof daniel hoyer

  179. Pharmacological characterisation of human cerebral cortex somatostatin SRIF1 and SRIF2 receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 1997, Springer Science + Business Media

    Prof daniel hoyer

  180. Minireview: Nomenclature and Classification of Transmitter Receptors: an Integrated Approach

    Article • Journal of Receptors and Signal Transduction, January 1997, Taylor & Francis

    Prof daniel hoyer

  181. Presence of somatostatin sst2 receptors in the developing rat auditory system

    Article • Developmental Brain Research, December 1996, Elsevier

    Prof daniel hoyer

  182. Status of somatostatin receptor messenger RNAs and binding sites in rat brain during kindling epileptogenesis

    Article • Neuroscience, December 1996, Elsevier

    Prof daniel hoyer

  183. Binding properties of somatostatin receptor subtypes

    Article • Metabolism, August 1996, Elsevier

    Prof daniel hoyer

  184. Somatostatin receptors in the Rhesus monkey brain: localization and pharmacological characterization

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, May 1996, Springer Science + Business Media

    Prof daniel hoyer

  185. Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes

    Article • Trends in Pharmacological Sciences, March 1996, Elsevier

    Prof daniel hoyer

  186. Somatostatin receptors in the developing rat brain

    Article • European Journal of Pharmacology, February 1996, Elsevier

    Prof daniel hoyer

  187. Classification and nomenclature of 5-HT receptors: a comment on current issues

    Article • Behavioural Brain Research, December 1995, Elsevier

    Prof daniel hoyer

  188. Embryonic and postnatal mRNA distribution of five somatostatin receptor subtypes in the rat brain

    Article • Neuropharmacology, December 1995, Elsevier

    Prof daniel hoyer

  189. Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera

    Article • Neuropharmacology, December 1995, Elsevier

    Prof daniel hoyer

  190. The Serotonin 5-HT4 Receptor. 1. Design of a New Class of Agonists and Receptor Map of the Agonist Recognition Site

    Article • Journal of Medicinal Chemistry, June 1995, American Chemical Society (ACS)

    Prof daniel hoyer

  191. The Serotonin 5-HT4 Receptor. 2. Structure-Activity Studies of the Indole Carbazimidamide Class of Agonists

    Article • Journal of Medicinal Chemistry, June 1995, American Chemical Society (ACS)

    Prof daniel hoyer

  192. Functional effects of d-Phe-c[Cys-Tyr-d-Trp-Lys-Val-Cys]-Trp-NH2 and differential changes in somatostatin receptor messenger RNAs, binding sites and somatostatin release in kainic acid-treated rats

    Article • Neuroscience, April 1995, Elsevier

    Prof daniel hoyer

  193. Characterization and distribution of somatostatin SS-1 and SRIF-1 binding sites in rat brain: identitity with SSTR-2 receptors

    Article • European Journal of Pharmacology Molecular Pharmacology, March 1995, Elsevier

    Prof daniel hoyer

  194. Classification and nomenclature of somatostatin receptors

    Article • Trends in Pharmacological Sciences, March 1995, Elsevier

    Prof daniel hoyer

  195. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors

    Article • European Journal of Pharmacology Molecular Pharmacology, March 1995, Elsevier

    Prof daniel hoyer

  196. Co-expression of somatostatin SSTR-3 and SSTR-4 receptor messenger RNAs in the rat brain

    Article • Neuroscience, January 1995, Elsevier

    Prof daniel hoyer

  197. Molecular pharmacology of somatostatin receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1994, Springer Science + Business Media

    Prof daniel hoyer

  198. Chromic mianserin or eltoprazine treatment in rats: effects on the elevated plus-maze test and on limbic 5-HT2C receptor levels

    Article • European Journal of Pharmacology, September 1994, Elsevier

    Prof daniel hoyer

  199. Molecular Pharmacology of Somatostatin-receptor Subtypes

    Article • Annals of the New York Academy of Sciences, September 1994, Wiley

    Prof daniel hoyer

  200. Localization of 5-HT1B, 5-HT1Dα, 5-HT1E and 5-HT1F receptor messenger RNA in rodent and primate brain

    Article • Neuropharmacology, March 1994, Elsevier

    Prof daniel hoyer

  201. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, February 1994, Springer Science + Business Media

    Prof daniel hoyer

  202. A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands

    Article • Molecular Brain Research, January 1994, Elsevier

    Prof daniel hoyer

  203. Effect of 5,7-dihydroxytryptamine lesion on mianserin-induced conditioned place aversion and on 5-hydroxytryptamine1C receptors in the rat brain

    Article • Neuroscience, October 1993, Elsevier

    Prof daniel hoyer

  204. Endothelin receptors in the human coronary artery, ventricle and atrium

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, October 1993, Springer Science + Business Media

    Prof daniel hoyer

  205. Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain

    Article • FEBS Letters, September 1993, Wiley

    Prof daniel hoyer

  206. Calcineurin inhibits desensitization of cloned rat 5-HT1C receptors

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, September 1993, Springer Science + Business Media

    Prof daniel hoyer

  207. Partial agonists, full agonists, antagonists: dilemmas of definition

    Article • Trends in Pharmacological Sciences, July 1993, Elsevier

    Prof daniel hoyer

  208. The novel 5-HT1A receptor antagonist, SDZ 216-525, decreases 5-HT release in rat hippocampus in vivo

    Article • British Journal of Pharmacology, July 1993, Wiley

    Prof daniel hoyer

  209. A proposed new nomenclature for 5-HT receptors

    Article • Trends in Pharmacological Sciences, June 1993, Elsevier

    Prof daniel hoyer

  210. Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, June 1993, Springer Science + Business Media

    Prof daniel hoyer

  211. 5-Hydroxytryptamine1 recognition sites in rat brain: Heterogeneity of non-5-hydroxytryptamine1a/1c binding sites revealed by quantitative receptor autoradiography

    Article • Neuroscience, March 1993, Elsevier

    Prof daniel hoyer

  212. SDZ 216–525, a selective and potent 5-HT1A receptor antagonist

    Article • European Journal of Pharmacology Molecular Pharmacology, February 1993, Elsevier

    Prof daniel hoyer

  213. Evidence for the presence of 5-HT1B receptor messenger RNA in neurons of the rat trigeminal ganglia

    Article • European Journal of Pharmacology Molecular Pharmacology, November 1992, Elsevier

    Prof daniel hoyer

  214. Agonist/antagonist interactions with cloned human 5-HT1A receptors: variations in intrinsic activity studied in transfected HeLa cells

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, March 1992, Springer Science + Business Media

    Prof daniel hoyer

  215. Direct visualization of serotonin1D receptors in the human brain using a new iodinated radioligand

    Article • Molecular Brain Research, March 1992, Elsevier

    Prof daniel hoyer

  216. 5-Hydroxytryptamine (5-HT) receptor superfamilies

    Article • Neurochemistry International, January 1992, Elsevier

    Prof daniel hoyer

  217. Homogeneous 5-HT1D recognition sites in the human substantia nigra identified with a new iodinated radioligand

    Article • European Journal of Pharmacology, September 1991, Elsevier

    Prof daniel hoyer

  218. Competitive antagonism by recognised 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, August 1991, Springer Science + Business Media

    Prof daniel hoyer

  219. Interaction of the α-adrenoceptor agonist oxymetazoline with serotonin 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D receptors

    Article • European Journal of Pharmacology, April 1991, Elsevier

    Prof daniel hoyer

  220. 5-HT1-like receptors mediate 5-hydroxytryptamine-induced contraction of guinea-pig isolated iliac artery

    Article • British Journal of Pharmacology, February 1991, Wiley

    Prof daniel hoyer

  221. Receptor biochemistry and methodology volume 15: Serotonin receptor subtypes

    Article • Trends in Pharmacological Sciences, January 1991, Elsevier

    Prof daniel hoyer

  222. 5-HT Receptors: Subtypes and Second Messengers

    Article • Journal of Receptor Research, January 1991, Taylor & Francis

    Prof daniel hoyer

  223. Autoradiography of 5-HT receptors: A critical appraisal

    Article • Neurochemistry International, January 1991, Elsevier

    Prof daniel hoyer

  224. Distribution of Serotonin Receptors

    Article • Annals of the New York Academy of Sciences, October 1990, Wiley

    Prof daniel hoyer

  225. The serotonin 5-HT1D receptor: A progress review

    Article • Neurochemical Research, June 1990, Springer Science + Business Media

    Prof daniel hoyer

  226. Receptor modification in the brains of spontaneously hypertensive and Wistar-Kyoto rats: regionally specific and selective increase in cerebellar beta 2-adrenoceptors.

    Article • British Journal of Clinical Pharmacology, February 1990, Wiley

    Prof daniel hoyer

  227. Similar distribution of [125I]sarafotoxin-6b and [125I]endothelin-1, -2, -3 binding sites in the human kidney

    Article • European Journal of Pharmacology, February 1990, Elsevier

    Prof daniel hoyer

  228. Selective Agonists and Antagonists at 5-Hydroxytryptamine Receptor Subtypes

    Article • January 1990, Springer Science + Business Media

    Prof daniel hoyer

  229. Subtypes of α1-adrenoceptors in hippocampus of pigs, guinea-pigs, calves and humans: regional differences

    Article • European Journal of Pharmacology Molecular Pharmacology, January 1990, Elsevier

    Prof daniel hoyer

  230. Interaction of psychotropic drugs with central 5-HT3 recognition sites: fact or artifact?

    Article • European Journal of Pharmacology, November 1989, Elsevier

    Prof daniel hoyer

  231. Is the sumatripan (GR 43175)-induced endothelium-dependent relaxation of pig coronary arteries mediated by 5-HT1D receptors?

    Article • European Journal of Pharmacology, July 1989, Elsevier

    Prof daniel hoyer

  232. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, July 1989, Springer Science + Business Media

    Prof daniel hoyer

  233. Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain

    Article • Trends in Pharmacological Sciences, April 1989, Elsevier

    Prof daniel hoyer

  234. 5-Hydroxytryptamine3 receptors in the human brain: Autoradiographic visualization using [3H]ICS 205-930

    Article • Neuroscience, January 1989, Elsevier

    Prof daniel hoyer

  235. Competitive Interaction of Agonists and Antagonists with 5-HT3-Recognition Sites in Membranes of Neuroblastoma Cells Labelled with [3H] ICS 205–930

    Article • Journal of Receptor Research, January 1989, Taylor & Francis

    Prof daniel hoyer

  236. Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS

    Article • European Journal of Pharmacology, July 1988, Elsevier

    Prof daniel hoyer

  237. Molecular pharmacology of 5-HT1D recognition sites: Radioligand binding studies in human, pig and calf brain membranes

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, June 1988, Springer Science + Business Media

    Prof daniel hoyer

  238. The 5-hydroxytryptamine 5-HT1D receptor subtype is negatively coupled to adenylate cyclase in calf substantia nigra

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, June 1988, Springer Science + Business Media

    Prof daniel hoyer

  239. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, May 1988, Springer Science + Business Media

    Prof daniel hoyer

  240. Visualization of a novel serotonin recognition site (5-HT1D) in the human brain by autoradiography

    Article • Neuroscience Letters, May 1988, Elsevier

    Prof daniel hoyer

  241. [125I]SCH 23982, a ‘selective’ D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus

    Article • European Journal of Pharmacology, May 1988, Elsevier

    Prof daniel hoyer

  242. Central 5-HT1A Receptors and the Mechanism of the Central Hypotensive Effect of (+)8-OH-DPAT, DP-5-CT, R28935, and Urapidil

    Article • Journal of Cardiovascular Pharmacology, April 1988, Wolters Kluwer Health

    Prof daniel hoyer

  243. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites

    Article • Neuroscience Letters, March 1988, Elsevier

    Prof daniel hoyer

  244. Molecular pharmacology and biology of 5-HT1C receptors

    Article • Trends in Pharmacological Sciences, March 1988, Elsevier

    Prof daniel hoyer

  245. 5-HT1D receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in calf substantia nigra

    Article • European Journal of Pharmacology, February 1988, Elsevier

    Prof daniel hoyer

  246. Functional Correlates of Serotonin 5-HT1Recognition Sites

    Article • Journal of Receptor Research, January 1988, Taylor & Francis

    Prof daniel hoyer

  247. Identification of serotonin 5-HT3 recognition sites by radioligand binding in NG108-15 neuroblastoma-glioma cells

    Article • European Journal of Pharmacology, November 1987, Elsevier

    Prof daniel hoyer

  248. α1-adrenoceptors in the mammalian brain: similar pharmacology but different distribution in rodents and primates

    Article • Brain Research, September 1987, Elsevier

    Prof daniel hoyer

  249. [3H]Ketanserin labels 5-HT2 receptors and ?1-adrenoceptors in human and pig brain membranes

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, March 1987, Springer Science + Business Media

    Prof daniel hoyer

  250. Inhibition of 5-carboxamidotryptamine-induced relaxation of guinea-pig ileum correlates with [125I]LSD binding

    Article • European Journal of Pharmacology, September 1986, Elsevier

    Prof daniel hoyer

  251. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, August 1986, Springer Science + Business Media

    Prof daniel hoyer

  252. Serotonin increases the production of inositol phosphates and mobilises calcium via the 5-HT2 receptor in A7r5 smooth muscle cells

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, June 1986, Springer Science + Business Media

    Prof daniel hoyer

  253. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites

    Article • Brain Research, June 1986, Elsevier

    Prof daniel hoyer

  254. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites

    Article • Brain Research, June 1986, Elsevier

    Prof daniel hoyer

  255. Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 1986, Springer Science + Business Media

    Prof daniel hoyer

  256. Implications of stereoselectivity in radioligand binding studies

    Article • Trends in Pharmacological Sciences, January 1986, Elsevier

    Prof daniel hoyer

  257. Characterization of the 5-HTIB recognition site in rat brain: Binding studies with (−)[125I]Iodocyanopindolol

    Article • European Journal of Pharmacology, November 1985, Elsevier

    Prof daniel hoyer

  258. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: Radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (−)[125I]iodocyanopindolol, [3H]mesulergine and [3H]Ketanserin

    Article • European Journal of Pharmacology, November 1985, Elsevier

    Prof daniel hoyer

  259. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: Evidence for species differences in brain serotonin-2 receptors

    Article • European Journal of Pharmacology, November 1984, Elsevier

    Prof daniel hoyer

  260. The binding of serotonergic ligands to the porcine choroid plexus: Characterization of a new type of serotonin recognition site

    Article • European Journal of Pharmacology, November 1984, Elsevier

    Prof daniel hoyer

  261. Characterization of IBE 2254 Binding to Alpha - Adrenergic Receptors on Intact DDT Smooth Muscle Cells: Comparison with Membrane1Binding and Correlation with Phosphoinositides Breakdown

    Article • Journal of Receptor Research, January 1984, Taylor & Francis

    Prof daniel hoyer

  262. Identification of 5HT2-Receptors on Longitudinal Muscle of the Guinea Pig Ileum

    Article • Journal of Receptor Research, January 1984, Taylor & Francis

    Prof daniel hoyer

  263. Binding of125I-Cyanopindolol to Beta-1-Adreno-Ceptors in a High and Low Affinity State

    Article • Journal of Receptor Research, January 1983, Taylor & Francis

    Prof daniel hoyer

  264. Non-specific uptake of the radioligand 125I-IHYP by intact human lymphocytes: Reversal of the uptake process

    Article • Molecular and Cellular Endocrinology, March 1982, Elsevier

    Prof daniel hoyer

  265. Binding characteristics of (+)-, (�)- and (-)-[125Iodo] cyanopindolol to guinea-pig left ventricle membranes

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, January 1982, Springer Science + Business Media

    Prof daniel hoyer

  266. (�)[125Iodo]cyanopindolol, a new ligand for ?-adrenoceptors: Identification and quantitation of subclasses of ?-adrenoceptors in guinea pig

    Article • Naunyn-Schmiedeberg s Archives of Pharmacology, November 1981, Springer Science + Business Media

    Prof daniel hoyer

  267. The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radio-ligand, (±)−125iodocyanopindolol

    Article • Life Sciences, November 1981, Elsevier

    Prof daniel hoyer

  268. [125I]BE 2254, a new high affinity radioligand for α1-adrenoceptors

    Article • European Journal of Pharmacology, July 1981, Elsevier

    Prof daniel hoyer

  269. Assessing allosteric ligand-receptor interactions

    Article • Cambridge University Press

    Prof daniel hoyer

  270. Molecular biology of 5-HT receptors

    Article • Springer Science + Business Media

    Prof daniel hoyer

  271. Highly N-Methylated Somatostatin Analogs: Synthesis, Biological Activity and Structure-Activity Relationship Studies

    Article • Springer Science + Business Media

    Prof daniel hoyer

  272. Serotoninergic System

    Article • Springer Science + Business Media

    Prof daniel hoyer

  273. Somatostatin Receptor Gene Family - Subtype Selectivity for Ligand Binding

    Article • Springer Science + Business Media

    Prof daniel hoyer